Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 18/20 | 1.00 |
| ▸ | ROCK1 | Q13464 | 16/20 | 1.00 |
| ▸ | RPS6KA1 | Q15418 | 15/20 | 1.00 |
| ▸ | AKT2 | P31751 | 13/20 | 1.00 |
| ▸ | AKT3 | Q9Y243 | 6/20 | 1.00 |
| ▸ | RPS6KA5 | O75582 | 7/20 | 0.82 |
| ▸ | GSK3B | P49841 | 3/20 | 0.75 |
| ▸ | CIT | O14578 | 1/20 | 0.75 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.75 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.75 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.75 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.75 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.75 |
| ▸ | ULK1 | O75385 | 1/20 | 0.75 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.75 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.75 |
| ▸ | SMC2 | O95347 | 1/20 | 0.75 |
| ▸ | LATS1 | O95835 | 1/20 | 0.75 |
| ▸ | PAK4 | O96013 | 1/20 | 0.75 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10053680 | 0.94 | AKT1 (0.91) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| Hydrochloric Acid SCHEMBL690160 | 0.94 | AKT1 (0.90) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| SCHEMBL3487696 | 0.90 | AKT1 (1.00) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| SCHEMBL3488233 | 0.90 | AKT1 (0.81) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| SCHEMBL15446768 | 0.87 | AKT1 (0.83) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| Gsk-690693 SCHEMBL2195376 | 0.86 | AKT1 (1.00) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| Gsk-690693 SCHEMBL310452 | 0.86 | AKT1 (1.00) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| Trifluoroacetic Acid SCHEMBL3488230 | 0.85 | AKT1 (0.88) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| Trifluoroacetic Acid SCHEMBL4291984 | 0.84 | AKT1 (0.73) | AKT1ROCK1RPS6KA1AKT2AKT3 | |
| Trifluoroacetic Acid SCHEMBL3488625 | 0.84 | AKT1 (0.88) | AKT1ROCK1RPS6KA1AKT2AKT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100056523-A1 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION | 2010-03-04 | — | — | US | disclosed |
| US-7625890-B2 | Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors | SMITHKLINE BEECHAM CORP. (US) | 2009-12-01 | — | — | US | disclosed |
| US-20090227616-A1 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION, A CORPORATION | 2009-09-10 | — | — | US | disclosed |
| US-20080269131-A1 | Protein kinase B ; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; cancer and arthritis | SMITHKLINE BEECHAM CORPORATION | 2008-10-30 | — | — | US | disclosed |
| US-20080255143-A1 | Inhibitors of Akt Activity | SMITHKLINE BEECHAM CORPORATION (PA) | 2008-10-16 | — | — | US | disclosed |
| EP-1954286-A2 | INHIBITORS OF AKT ACTIVITY | SmithKline Beecham Corporation (US) | 2008-08-13 | — | — | EP | disclosed |
| EP-1948185-A2 | INHIBITORS OF AKT ACTIVITY | SmithKline Beecham Corporation (US) | 2008-07-30 | — | — | EP | disclosed |
| EP-1948188-A2 | INHIBITORS OF AKT ACTIVITY | SmithKline Beecham Corporation (US) | 2008-07-30 | — | — | EP | disclosed |
| US-20080076763-A1 | Inhibitors of Akt activity | GLAXOSMITHKLINE LLC | 2008-03-27 | — | — | US | disclosed |
| WO-2007058879-A2 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007058850-A2 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007058852-A2 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2007-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227616-A1 | INHIBITORS OF AKT ACTIVITY | PI4KB, PIK3CA, AKT2 | AKT1 5/4885ROCK1 478/4885RPS6KA1 127/4885 |
| US-20080076763-A1 | Inhibitors of Akt activity | PI4KB, PIK3CA, AKT2 | AKT1 5/4885ROCK1 478/4885RPS6KA1 127/4885 |
| US-20100056523-A1 | INHIBITORS OF AKT ACTIVITY | PI4KB, PIK3CA, AKT2 | AKT1 5/4885ROCK1 478/4885RPS6KA1 127/4885 |
| US-20080269131-A1 | Protein kinase B ; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; cancer and arthritis | MAP4K2, MAPKAPK2, PTK2B | AKT1 254/4885ROCK1 434/4885RPS6KA1 216/4885 |
| US-20080255143-A1 | Inhibitors of Akt Activity | PI4KB, PIK3CA, AKT2 | AKT1 5/4885ROCK1 478/4885RPS6KA1 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.